Abrahm Levi

900 total citations · 1 hit paper
10 papers, 525 citations indexed

About

Abrahm Levi is a scholar working on Oncology, Geriatrics and Gerontology and Epidemiology. According to data from OpenAlex, Abrahm Levi has authored 10 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Geriatrics and Gerontology and 3 papers in Epidemiology. Recurrent topics in Abrahm Levi's work include Frailty in Older Adults (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Breast Cancer Treatment Studies (2 papers). Abrahm Levi is often cited by papers focused on Frailty in Older Adults (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Breast Cancer Treatment Studies (2 papers). Abrahm Levi collaborates with scholars based in United States and Switzerland. Abrahm Levi's co-authors include Vani Katheria, Hyman B. Muss, Supriya G. Mohile, Heidi D. Klepin, Arti Hurria, Harvey Jay Cohen, William P. Tew, Can-Lan Sun, David Smith and Chie Akiba and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Oncologist.

In The Last Decade

Abrahm Levi

9 papers receiving 521 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer

2016 402 citations Arti Hurria, Supriya G. Mohile et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Abrahm Levi

Since Specialization

Citations

This map shows the geographic impact of Abrahm Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abrahm Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abrahm Levi more than expected).

Fields of papers citing papers by Abrahm Levi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abrahm Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abrahm Levi. The network helps show where Abrahm Levi may publish in the future.

Co-authorship network of co-authors of Abrahm Levi

This figure shows the co-authorship network connecting the top 25 collaborators of Abrahm Levi. A scholar is included among the top collaborators of Abrahm Levi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abrahm Levi. Abrahm Levi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database 2025 ·The Oncologist ·Abrahm Levi, Edik M. Blais, (unknown), (unknown), (unknown), (unknown), Gillian Gresham, Lei Zheng, (unknown), Rachna T. Shroff, Raymond Wadlow, Patricia DeArbeloa, Lynn M. Matrisian, Emmanuel Petricoin, Michael J. Pishvaian, Jun Gong, Andrew Hendifar, Arsen Osipov	0
2	Preliminary translational immune and stromal correlates in a randomized phase II trial of pembrolizumab with or without defactinib for resectable pancreatic ductal adenocarcinoma (PDAC). 2023 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), Abrahm Levi, (unknown), (unknown), (unknown), Jonathan A. Pachter, Jun Gong, Brent K. Larson, Andrew Hendifar, Simon S. Lo, Srinivas Gaddam, Kambiz Kosari, Nicholas N. Nissen, Stephen J. Pandol, Richard A. Burkhart, Lei Zheng, Arsen Osipov	5
3	Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal Cancers 2022 ·The Oncologist ·Daneng Li, Can‐Lan Sun, Rebecca Allen, Christiana Crook, Abrahm Levi, (unknown), Heidi D. Klepin, (unknown), Supriya G. Mohile, William P. Tew, Cynthia Owusu, Hyman B. Muss, Stuart M. Lichtman, Cary P. Gross, Andrew E. Chapman, Ajeet Gajra, Harvey Jay Cohen, Vani Katheria, Arti Hurria, William Dale	3
4	Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer 2021 ·Journal of Clinical Oncology ·Allison Magnuson, Mina S. Sedrak, Cary P. Gross, William P. Tew, Heidi D. Klepin, Tanya M. Wildes, Hyman B. Muss, Efrat Dotan, Rachel A. Freedman, Tracey L. O’Connor, William Dale, Harvey Jay Cohen, Vani Katheria, (unknown), Abrahm Levi, Heeyoung Kim, Supriya G. Mohile, Arti Hurria, Can-Lan Sun	76
5	Abstract PD10-10: Factors associated with decreased relative dose intensity in older adults with early-stage breast cancer receiving chemotherapy 2020 ·Cancer Research ·Mina S. Sedrak, Can‐Lan Sun, Allison Magnuson, Hyman B. Muss, Rachel A. Freedman, Cary P. Gross, William P. Tew, Heidi D. Klepin, Tanya M. Wildes, Efrat Dotan, Tracey L. O’Connor, Harvey Jay Cohen, Heeyoung Kim, Vani Katheria, Reena Jayani, (unknown), Abrahm Levi, Kemeberly Charles, Arti Hurria, William Dale	1
6	Abstract GS6-04: Development and validation of a chemotherapy toxicity (Chemo Tox) risk score for older patients (Pts) with breast cancer (BC) receiving adjuvant/neoadjuvant treatment (Adjuvant Tx): A R01 and BCRF funded prospective multicenter study 2019 ·Cancer Research ·Arti Hurria, Allison Magnuson, (unknown), (unknown), (unknown), (unknown), Muss Hb, Efrat Dotan, Rachel A. Freedman, Tracey L. O’Connor, William Dale, HJ Cohen, Vani Katheria, (unknown), Abrahm Levi, Helen Kim, (unknown)	11
7	Abstract P5-21-08: Tolerability of the combination of lapatinib and trastuzumab in older patients with HER2 positive metastatic breast cancer 2018 ·Cancer Research ·(unknown), Enrique Soto‐Pérez‐de‐Celis, Suzette Blanchard, Aaron Chapman, (unknown), H. B. Muss, (unknown), (unknown), (unknown), (unknown), Yuan Yuan, George Somlo, Doug Stewart, Vani Katheria, Abrahm Levi, A. Hurria	4
8	Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer breakdown → 2016 ·Journal of Clinical Oncology ·Arti Hurria, Supriya G. Mohile, Ajeet Gajra, Heidi D. Klepin, Hyman B. Muss, Andrew E. Chapman, Feng Tao, David Smith, Can-Lan Sun, Nienke A. de Glas, Harvey Jay Cohen, Vani Katheria, (unknown), Laura Zavala, Abrahm Levi, Chie Akiba, William P. Tew	402
9	Species differences and geographic variation in the communal roosting behavior ofPrionostemmaharvestmen in Central American rainforests 2014 ·Journal of Arachnology ·Gregory F. Grether, (unknown), (unknown), Abrahm Levi, (unknown), Victor R. Townsend	13
10	Communal roosting sites are potential ecological traps: experimental evidence in a Neotropical harvestman 2014 ·Behavioral Ecology and Sociobiology ·Gregory F. Grether, Abrahm Levi, (unknown), Debra M. Shier	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact